The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor stroma proportion to predict platinum chemoresistance in primary ovarian carcinomas: A prospective study.
 
Emil Lou
Honoraria - GlaxoSmithKline; Novocure
Research Funding - Novocure
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Rachel Isaksson Vogel
Consulting or Advisory Role - Voluntis
Patents, Royalties, Other Intellectual Property - USP14 as a biomarker for endometrial cancer (Inst)
 
Spencer Hoostal
No Relationships to Disclose
 
Aaron Grad
No Relationships to Disclose
 
Minnu Monu
No Relationships to Disclose
 
Tomasz Lukaszewski
No Relationships to Disclose
 
Jaai Deshpande
No Relationships to Disclose
 
Michael Linden
No Relationships to Disclose
 
Molly Klein
No Relationships to Disclose
 
Deanna Gek Koon Teoh
Research Funding - KCI
 
Melissa Ann Geller
Speakers' Bureau - Tesaro
Research Funding - Bayer; FATE Therapeutics; Genentech; Morphotek; Ovagene Oncology; Tesaro